摘要
目的:探讨血清心肌肌钙蛋白I(cTnI)对判断急性心肌梗死(AMI)治疗效果的作用。方法:在进行溶栓治疗的同时,测定96例AMI患者血清中的cTnI和与肌酸激酶同工酶(CK-MB),并观察其动态变化。结果:入院72h内,cTnI检测阳性率明显高于CK-MB(P<0.01)。cTnI和CK-MB开始升高时间在溶栓再通者中有显著性差异(P<0.01);在溶栓未通者中无显著性差异(P>0.05)。cTnI与CK-MB高峰出现时间在溶栓未通者中有显著性差异(P<0.01);在溶栓再通者中无显著性差异(P>0.05)。cTn I与CK-MB恢复正常时间在溶栓再通者与溶栓未通者中均有显著性差异(P<0.01)。结论:动态检测cTnI对判断AMI治疗效果较CK-MB更有价值。
Objective： To investigate the effect of serum cardiac troponin I（cTnI）testing on the therapeutical judgement of the acute myocardial infarction c（AMI）.Method： During thrombolytic therapy at the same time,serum cTnI and creatine kinase（CK-MB）in 96 cases with AMI were measured,and its dynamics was observed.Result： Admission within 72h,cTnI positive rate was significantly higher than that of CK-MB（P 0.01）.The time of cTnI and CK-MB beginning to rise had significant difference（P 0.01） in the hrombolytic recanalization patients;thrombolytic who did not pass without significant difference（P 0.05）.The peak times of cTnI and CK-MB had a significant difference（P 0.01）in the thrombolysis who did not pass;who thrombolytic recanalization was no significant difference（P 0.05）.cTnI and CK-MB recovery time in the thrombolytic thrombolytic recanalization and those who did not pass were significant differences（P 0.01）.Conclusion： Dynamic detection of cTnI for AMI is more valuable than CK-MB in determining the treatment effect.
出处
《河北医学》
CAS
2012年第3期322-324,共3页
Hebei Medicine
